News Article,Video
Maple Grove Medical Device Company Shares How They are Surviving During COVID-19
October 5, 2020
CCX Media visited Francis Medical on September 30, 2020, to interview President and CEO Mike Kujak, and get an inside look at how we’re thriving and moving forward during the COVID-19 pandemic, including a $4M investment from world-renown urology company, Coloplast. (2 1/2 min video)
Recent Posts
Francis Medical Announces First Commercial Vanquish® Procedure on the East Coast for Prostate Tissue Ablation
Minneapolis, MN [March. 25, 2026] – Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical study) procedure on the East Coast using the Vanquish® Water Vapor Ablation System, a minimally invasive technology designed to ablate targeted prostate tissue while potentially helping to preserve urinary and sexual function.
Francis Medical Announces First Commercial Vanquish® Procedures in Arizona for Prostate Tissue Ablation
MINNEAPOLIS (March 5, 2026) – Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water Vapor Ablation System for prostate tissue ablation.
Francis Medical Announces First Commercial Procedure with the Vanquish® Water Vapor System for Prostate Tissue Ablation
MINNEAPOLIS (Feb 3, 2026) – Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System
Federal law (USA) restricts this device to sale by or on the order of a physician.
Refer to the device User Manual for a list of contraindications, warnings, and cautions.
Training: Do not operate the Vanquish System without completing Francis Medical-provided physician training. Untrained operation of the device may lead to improper use. Improper use can result in patient injury or equipment malfunction.